Is it time to buy National Australia Bank Ltd., Macquarie Group Ltd and Westpac Banking Corp?

Macquarie Group Ltd (ASX:MQG) has been kicking goals for shareholders in 2015, but National Australia Bank Ltd (ASX:NAB) and Westpac Banking Corp (ASX:WBC) haven't kept pace with the market. Will their fortunes reverse in the back half of 2015?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So far in 2015, shares of Australia's major banks like Westpac Banking Corp (ASX: WBC) and National Australia Bank Ltd. (ASX: NAB) haven't performed nearly as well as shareholders would've liked.

Indeed, both Westpac and NAB have underperformed the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) by a hefty 5%.

However, the one shining the light for bank shareholders has been Macquarie Group Ltd (ASX: MQG), Australia's largest investment bank.

Up an astounding 38% for the year Macquarie has continued to post stronger profits on the back of bounding global sharemarkets and currency movements.

Is it time to buy these three bank stocks?

Following a rise of 3% in 2014, shares of Westpac have risen just 1.3% since the beginning of January 2015, whilst the broader ASX is up 6%. Indeed, it appears investor enthusiasm for Westpac shares has soured in recent months after the $102 billion retail bank posted a lacklustre set of half-year results.

The outlook for medium-term unemployment, credit growth, and bank competition also places a cloud over Westpac's ability to continue driving record profits. The bank's CEO, Brian Hartzer, said shareholders can expect, "intense competition" in the banking sector and, "uneven" growth across the economy.

Following years of share price underperformance and one-off provisions and costs, NAB has earned the reputation as the most accident-prone of the big banks. However, its recent decision to divest part of its UK business could be the catalyst for a turnaround in the bank's fortunes. These subsidiaries, named Clydesdale Bank and Yorkshire Bank, have been the focal point of many regulatory and media investigations over the past decade.

Whilst NAB's divestment decision will likely prove to be worthwhile, like its peers, there's a strong possibility NAB's earnings will slow in coming years as the local economy enters a rough patch.

Finally, Macquarie Group shares have – unlike their two larger peers – handily outperformed the ASX over the past five years. In addition to its title as Australia's leading investment bank, Macquarie generates 70% of its income from overseas markets and is a specialist in infrastructure financing, leasing and funds management.

Macquarie's push into annuity-style areas of finance bodes well for sustainable returns over the market cycle. However, investors must remember that both retail and investment banking profits – and, therefore, their share price performances – are heavily leveraged to the market cycle.

Buy, Hold or Sell?

Personally, I'm not a buyer of bank stocks at today's prices. Despite shares in each of the big four retail banks falling heavily in 2015, I continue to believe a slowing economy will put a dampener on their ability to continue posting record profits. Unfortunately, neither NAB nor Westpac appears priced for their lower growth profiles.

On the other hand, I wouldn't be surprised to see Macquarie shares continue to climb in 2015. However, given their current price tag, it appears investors have recognised this potential and they do not appear great value for long-term investors.

Motley Fool contributor Owen Raskiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google plus (see below) or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »